FIME / WHX Miami vs Hospitalar for Exhibitors
Side-by-side data and our editorial take on which conference is the right exhibit investment for your medical device.
By Buzzbox Media · Last reviewed August 3, 2026
If you exhibit medical devices, FIME / WHX Miami and Hospitalar are likely both on your shortlist. Both serve overlapping clinical buyers, but the audience composition, booth economics, and exhibit floor experience differ in ways that materially affect ROI. FIME / WHX Miami draws 15,000 attendees with no booth pricing published by the organizer. Hospitalar draws 91,000 attendees with no booth pricing published by the organizer. Below is the side-by-side data plus our editorial take on which conference fits which kind of exhibitor.
| 7.2 FIME / WHX Miami | 9.5 Hospitalar | |
|---|---|---|
| Score | ||
| Buzzbox Score | 7.2 (Strong) | 9.5 (Exceptional) |
| Event Details | ||
| Dates | June 17-19, 2026 | May 19-22, 2026 |
| Location | Miami Beach Convention Center, Miami Beach, FL | Sao Paulo Expo Exhibition & Convention Center, Sao Paulo, Brazil |
| Scale | large | mega |
| Audience | ||
| Attendees | 15,000 | 91,000 |
| Exhibitors | n/a | n/a |
| Purchasing authority | ~50% | ~55% |
| Effective buyers | 7,500 | 50,050 |
| Costs | ||
| $/sqft | n/a | n/a |
| 10×10 space | n/a | n/a |
| All-in estimate | n/a | n/a |
| Cost per buyer | n/a | n/a |
Why exhibit at FIME / WHX Miami
The #1 show for reaching Latin American and Caribbean healthcare buyers from US soil. Miami location eliminates visa and logistics complexity that Hospitalar (Brazil) presents. If you want LatAm distribution without leaving the US, this is it.
Why exhibit at Hospitalar
The #1 gateway to Latin America's healthcare markets. Brazil alone is the 6th largest medical device market globally. 91,000+ attendees with significant government procurement officers make this essential for companies expanding into LatAm.
Why skip FIME / WHX Miami
Not a clinical/scientific conference: no educational sessions or CME credits drive traffic. US domestic buyers have better options at specialty-specific shows. Attendance is lower-density than the big mega shows (15k vs 90k at Hospitalar), so lead volume per dollar is lower if your primary target is Brazil specifically.
Why skip Hospitalar
Brazil's ANVISA regulatory pathway is complex and slow. Companies without existing Brazilian registration or a local importer/distributor will collect leads they can't convert for 12-24 months. Portuguese-language materials are essential. English-only booths underperform badly.
FIME / WHX Miami publishes no booth pricing we can link to, so no cost is listed for it. See the official FIME / WHX Miami site ↗ for exhibitor details. Hospitalar publishes no booth pricing we can link to, so no cost is listed for it. See the official Hospitalar site ↗ for exhibitor details. Confirm current pricing with each organizer before committing a budget.
Frequently Asked Questions
Does FIME / WHX Miami or Hospitalar have more decision makers?
Hospitalar does, on our estimate: roughly 50,050 effective buyers against about 7,500 at FIME / WHX Miami. Effective buyers multiplies total attendance by the share of attendees who hold purchasing authority, so Hospitalar works out to about 91,000 attendees at roughly 55% authority, and FIME / WHX Miami to about 15,000 at roughly 50%. Both inputs are estimates drawn from organizer reporting and our own exhibitor research, so read the gap as directional rather than exact.
Want to add a third conference to this comparison?
Compare these conferences in our interactive tool →Other conferences you might consider
Buzzbox Media is a medtech marketing agency with over 15 years in medtech. See our conference marketing.